https://socictopen.socict.org/files/original/4d53ef24375cbf715d011eb168efba3e.pdf a69463abff68824a64e0155936b77d67 Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Current Options in the Treatment of COVID-19: A Review Creator An entity primarily responsible for making the resource Teimury A, Mahmoodi Khaledi E Description An account of the resource Azadeh Teimury, Elahe Mahmoodi Khaledi Department of Cell and Molecular Biology, Faculty of Chemistry, University of Kashan, Kashan, IranCorrespondence: Elahe Mahmoodi KhalediDepartment of Cell and Molecular Biology, Faculty of Chemistry, University of Kashan, Kashan, IranTel +9831-55913042Fax +9831-55511121Email e.mahmoodi_kh@kashanu.ac.irAbstract: Novel Coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and spread rapidly all around the world infecting many people. To date, no specific vaccines and drugs have been developed for this disease. Also, due to the COVID-19 pandemic and high prevalence of the infected patients, the drugs and the therapies of other past viral epidemics have been used for this disease. Many studies have been performed on the specific treatments to find whether or not they are effective on COVID-19 patients. In this review, we collected information about the most widely used drugs to treat COVID-19 (coronavirus disease 2019) belonging to groups of antivirals, antibiotics, immune modulators, and anticoagulants. Some of these compounds and drugs were used directly by inpatients, so researchers have examined others in laboratory conditions. This study considered the pros and cons of using these treatments separately and together and compared their results. By studying this review, we hope to provide useful information for researchers.Keywords: SARS-CoV-2, COVID-19, antiviral drugs, antibiotics, immune modulators, anticoagulants Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource covid-19, SARS-CoV-2, antiviral drugs, Antibiotics, anticoagulants, immune modulators Source A related resource from which the described resource is derived Biotemas Publisher An entity responsible for making the resource available Universidade Federal de Santa Catarina Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Public aspects of medicine